Moderna's Cancer Vaccine Breakthrough & Why Uber Could Win the Robotaxi War

Moderna's Cancer Vaccine Breakthrough & Why Uber Could Win the Robotaxi War

Author: MyWallSt August 27, 2026 Duration: 48:54

Moderna (NASDAQ:MRNA) is back in the headlines after phase three success for what's being called a cancer vaccine, built on the same mRNA technology that powered its Covid vaccine. We discuss just how significant it is that this treatment has gotten this far in trials, why the pandemic accelerated mRNA research faster than anyone expected, and why the commercial realities of personalized medicine, similar to the challenges facing CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals (NASDAQ:VRTX) with their multi million dollar sickle cell treatment, could complicate scalability even if the science works.

We make the case for why investing in a company trying to cure previously unsolvable diseases is worth serious consideration for stock investors, even beyond the pure economics, and why crossing a scientific milestone like this can open the floodgates for the rest of the biotech industry.

Then we shift to Uber (NYSE:UBER) and the case for why the robotaxi race may not be as simple as Waymo good, Uber bad. Rather than spending billions building its own autonomous vehicle fleet, Uber is positioning itself as the aggregator that Waymo, Zoox, Baidu and a growing list of AV players plug into. We break down CEO Dara Khosrowshahi's argument that the highest utilization operator will have the lowest cost of capital, and count the wave of robotaxi partnerships announced over just the last four months.

We close out on why this is not a simple binary bet, how Uber's ride hailing and delivery business has quietly become far more profitable in recent years, and why autonomous driving commoditization could actually favor Uber's asset light model as the technology scales globally.

Stocks mentioned:

  • Moderna Inc (NASDAQ:MRNA)
  • CRISPR Therapeutics AG (NASDAQ:CRSP)
  • Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
  • Uber Technologies Inc (NYSE:UBER)
  • Alphabet Inc / Waymo (NASDAQ:GOOGL)
  • Tesla Inc (NASDAQ:TSLA)
  • Amazon.com Inc / Zoox (NASDAQ:AMZN)
  • Lyft Inc (NASDAQ:LYFT)

#StockClub #MyWallst #ModernaStock #UberStock #CancerVaccine #RobotaxiStocks #StocksToBuy


Each week on Stock Club, the team from MyWallSt gathers to break down the movements and ideas shaping the market. This isn't about hype or frantic trading tips; it's a grounded conversation focused on understanding how investing actually works. You'll hear them analyze specific stock news and discuss the strategies behind building lasting wealth, all with the aim of making you a more thoughtful and confident investor. The discussion in this podcast naturally evolves from the week's most significant events, offering clarity on complex financial stories without relying on jargon. Tuning in feels like being part of a straightforward, informed discussion where the priority is long-term perspective over short-term noise. For anyone looking to deepen their grasp of the business and investing landscape, Stock Club provides a consistent, reliable space to learn. It’s the regular check-in that helps demystify the market's shifts, emphasizing education and insight as the true foundations for success. You can find Stock Club wherever you listen to podcasts.
Author: Language: English Episodes: 50

Stock Club
Podcast Episodes
#288: An International Multibagger Stock to Buy Right Now [not-audio_url] [/not-audio_url]

Duration: 57:01
After the recent launch of Nexus III and last week’s peek behind the curtain of Nexus I and II, we’re bringing you one more Nexus sample.Fresh from Nexus’ latest crop of stocks, Mike pitches a business essential to the A…
#287: 2 Stock with 10X Potential From Across the Globe [not-audio_url] [/not-audio_url]

Duration: 49:23
Mike and Emmet head back to foreign shores to talk about their favorite stocks from Nexus I and II in honor of the launch of Nexus III.Nexus, MyWallSt’s international portfolio, aims to ensure every long-term, high-growt…
#286: The S&P 500’s Most Undervalued Stock? [not-audio_url] [/not-audio_url]

Duration: 48:17
As SoftBank sells off its Nvidia holdings to free up capital for OpenAI, it might be time to look for something with a less eye-watering valuation.Adobe, once one of Wall Street’s most beloved SaaS players, is down nearl…
#285: What Stocks to Buy in a Market Crash? (w/ Sean Tepper) [not-audio_url] [/not-audio_url]

Duration: 38:20
This week, Mike is joined by Sean Tepper, the founder of Tykr, a platform focused on turning Wall Street newbies into confident investors.Like Mike and Emmet, Sean believes the stock market is a powerful tool for regular…
#284: The Warren Buffett Stock No One Is Talking About [not-audio_url] [/not-audio_url]

Duration: 48:56
In a surprise double feature, Mike and Emmet bring you two more “boring,” Peter Lynch–style businesses to ground your portfolio. In the wake of AI-fueled Big Tech layoffs, the market is undeniably frothy — so it’s a grea…
#283: 2 Cheap Value Stocks to Buy Right Now [not-audio_url] [/not-audio_url]

Duration: 57:35
Stock Club is usually home to high-risk, high-reward tech stocks on the cutting edge of tomorrow, but this week, Emmet and Mike bring you two down-to-earth value stocks that hold a special place in their hearts. While th…
#282: Is Intel a Turnaround Play? — INTC Stock Analysis [not-audio_url] [/not-audio_url]

Duration: 51:48
Emmet and Mike are back to discuss the latest stock market moves.Mike breaks down the U.S. government’s attempts to reduce reliance on foreign companies by investing in homegrown alternatives. The rare metals market is d…
#280: A Healthcare Stock on Emmet’s Watchlist [not-audio_url] [/not-audio_url]

Duration: 51:23
This week, Mike and Emmet venture onto the shores of the healthcare industry to identify some potential hundred-baggers.Emmet breaks down Oscar Health, a stock often discussed by investors on X and Reddit. The company wa…